tiprankstipranks
Trending News
More News >
Innovent Biologics (HK:1801)
:1801

Compare Innovent Biologics (1801) vs. Competitors

Compare
22 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Innovent Biologics
HK$81.10
HK$140.68B
109.18
145.39%
5 Buy
0 Hold
0 Sell
Strong Buy
Sino Biopharmaceutical
HK$6.83
HK$118.75B
29.75
135.46%
2 Buy
0 Hold
0 Sell
Moderate Buy
Wuxi Biologics (Cayman)
HK$37.00
HK$152.94B
33.19
100.87%
3 Buy
0 Hold
0 Sell
Strong Buy
Akeso, Inc.
HK$110.40
HK$101.69B
-108.45
81.43%
3 Buy
2 Hold
0 Sell
Moderate Buy
Shanghai Junshi Biosciences Co., Ltd. Class H
HK$21.38
HK$36.44B
-20.84
94.36%
0 Buy
1 Hold
0 Sell
Hold
Shanghai Henlius Biotech, Inc. Class H
HK$58.60
HK$31.14B
34.99
241.89%

Performance Comparison

Ticker
Company Name
Price
Change
% Change
HK:1801
Innovent Biologics
81.10
48.35
147.63%
HK:1177
Sino Biopharmaceutical
6.64
3.82
135.46%
HK:2269
Wuxi Biologics (Cayman)
37.00
18.52
100.22%
HK:9926
Akeso, Inc.
110.40
50.75
85.08%
HK:1877
Shanghai Junshi Biosciences Co., Ltd. Class H
21.38
10.78
101.70%
HK:2696
Shanghai Henlius Biotech, Inc. Class H
57.30
40.32
237.46%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts